Pilot Study to Investigate the Impact of an App on the Quality of Life and Symptoms of Individuals Affected by Menopause

Exclusion Criteria

• •Changes in hormone therapy within eight weeks before the start of the study and/or planned within the next 12 weeks
• •Changes in antidepressant treatment within eight weeks before the start of the study and/or planned within the next 12 weeks
• •Previous or current access to the Endo-App or other comparable digital health applications, or current active prescription
• •Current participation in other clinical studies